Polymorphisms in CPT1B and CPT2 have no significant effect on plasma carnitine levels in Japanese cancer patients

Treatment of cancer patients undergoing chemotherapy with L-carnitine (LC) supplementation is becoming increasingly popular in the clinic. The present study aimed to examine the possible effects of polymorphisms in CPT1B and CPT2 (CPT1B G320D, S427C, c.282-18 C>T, and p.E531K, and CPT2 V368I) on...

Descripción completa

Detalles Bibliográficos
Autores principales: Hishida, Asahi, Watanabe, Ryosuke, Hattori, Yuta, Okugawa, Yoshinaga, Shirai, Yumiko, Miki, Chikao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2019
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728200/
https://www.ncbi.nlm.nih.gov/pubmed/31579338
http://dx.doi.org/10.18999/nagjms.81.3.477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728200/
https://www.ncbi.nlm.nih.gov/pubmed/31579338
http://dx.doi.org/10.18999/nagjms.81.3.477

Ejemplares similares